Stock GRI GRI BIOPAR
Add to a list
To use this feature you must be a member
Log inSign up

Insiders GRI BIOPAR

Equities

GRI

US3622AW1069

Delayed Nasdaq
Other stock markets
 02:49:40 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.4301 USD +0.02% Intraday chart for GRI BIOPAR -18.55% -93.58%
Apr. 16 GRI Bio Receives South Korea Patent for Liver Inflammatory Condition Treatments MT
2023 Vallon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Vallon Pharmaceuticals, Inc. Announces Board Changes
CI
Vallon Pharmaceuticals, Inc. Announces Elimination of Penny S. Toren as Senior Vice President
CI
Vallon Pharmaceuticals, Inc. Announces Resignation of Ofir Levi as Member of the Board of Directors and as Chairman of the Board
CI
Vallon Pharmaceuticals, Inc. Announces Appointment of Meenu Karson to Board of Directors
CI
Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board
CI
Vallon Pharmaceuticals, Inc. Announces Executive Changes
CI
Vallon Pharmaceuticals Inc. Appoints Leanne Kelly as Chief Financial Officer
CI
Vallon Pharmaceuticals, Inc. Appoints Marella Thorell to the Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GRI Stock
  4. News GRI BIOPAR
  5. Insiders